Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
… Deborah Yoong reports personal fees from Merck and Gilead Science, outside the submitted
work. Cécile Tremblay reports grants and personal fees from Gilead, Merck, ViiV Healthcare…
work. Cécile Tremblay reports grants and personal fees from Gilead, Merck, ViiV Healthcare…
[HTML][HTML] Role of the pharmacist in caring for patients with HIV/AIDS: clinical practice guidelines
…, N Sheehan, S Stone, L Sulz, D Yoong - The Canadian journal …, 2012 - ncbi.nlm.nih.gov
Over the past decade, there have been numerous advances in HIV therapy, with 6 drug
classes comprising 24 individual antiretroviral agents now available. For patients who are …
classes comprising 24 individual antiretroviral agents now available. For patients who are …
A Potential Drug–Herbal Interaction between Ginkgo biloba and Efavirenz
M Naccarato, D Yoong… - Journal of the International …, 2012 - journals.sagepub.com
Efavirenz (EFV) is primarily metabolized by cytochrome P450 (CYP) 2B6 and to a lesser
extent by CYP3A4. Drugs that significantly inhibit or induce these enzymes would then be …
extent by CYP3A4. Drugs that significantly inhibit or induce these enzymes would then be …
Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study
D Yoong, AM Bayoumi, L Robinson… - … Open Access Journal, 2018 - cmajopen.ca
… Deborah Yoong and Tony Antoniou conceived the project; all authors contributed to designing
the study. Deborah Yoong … Deborah Yoong and Ahmed Bayoumi wrote the first draft of the …
the study. Deborah Yoong … Deborah Yoong and Ahmed Bayoumi wrote the first draft of the …
High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV
SA Morrison, D Yoong, TA Hart, P MacPherson… - PLoS …, 2018 - journals.plos.org
… Competing interests: We have read the journal's policy and the authors of this manuscript
have the following competing interests: Deborah Yoong has received honoraria from Gilead, …
have the following competing interests: Deborah Yoong has received honoraria from Gilead, …
Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis
D Yoong, M Naccarato, M Sharma… - … journal of STD & …, 2016 - journals.sagepub.com
Pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV transmission but
has the potential to cause harm if not used properly. Pharmacists are well-positioned to …
has the potential to cause harm if not used properly. Pharmacists are well-positioned to …
A case of a potential drug interaction between clobazam and etravirine-based antiretroviral therapy
M Naccarato, D Yoong, C Kovacs… - Antiviral therapy, 2012 - journals.sagepub.com
The cytochrome P450 isoforms primarily involved in clobazam metabolism are CYP3A4 and
2C19. Drugs that modulate these enzymes would then be expected to alter the exposure of …
2C19. Drugs that modulate these enzymes would then be expected to alter the exposure of …
Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid
T Antoniou, K Gough, D Yoong… - Clinical Infectious …, 2004 - academic.oup.com
A 42-year-old man with human immunodeficiency virus (HIV) infection and a history of complex
partial seizures developed severe anemia after the addition of valproic acid to his stable …
partial seizures developed severe anemia after the addition of valproic acid to his stable …
Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures
M Clifford Rashotte, D Yoong… - … journal of STD & …, 2024 - journals.sagepub.com
PEP-In-Pocket (Post-Exposure Prophylaxis-In-Pocket, or “PIP”) is a biobehavioural HIV
prevention strategy wherein patients are proactively identified and given a prescription for HIV …
prevention strategy wherein patients are proactively identified and given a prescription for HIV …
Probable hepatotoxicity with dolutegravir: Report of two cases and review of the literature
S Nhean, D Yoong, DK Wong, K Gough, AL Tseng - Aids, 2019 - journals.lww.com
Drug-induced liver injury (DILI) has been described with antiretrovirals including stavudine,
nevirapine, and protease inhibitors [1]. Dolutegravir is a widely used integrase strand-…
nevirapine, and protease inhibitors [1]. Dolutegravir is a widely used integrase strand-…